A survey of U.S. hematology-oncology fellows suggests medical school plays an important role in shaping their interest in pursuing careers in hematology, particularly when students are exposed to hematology and oncology as ...
Oct 31, 2019
0
1
With improved treatments, especially the use of anti-cancer immunotherapies, more than two-thirds of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) will survive. However, after treatment, patients are at ...
Oct 8, 2019
0
2
A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD, a medical oncologist at Memorial ...
Dec 7, 2014
0
1
FUJIFILM Corporation today announced to conduct a clinical trial of its anti-cancer drug FF-10101 in patients with relapsed or refractory acute myeloid leukemia (AML) in the United States next year. FF-10101 is a new drug ...
Nov 10, 2015
0
13
An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
Jun 4, 2012
0
0
A new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows that preparing older acute myeloid ...
Dec 10, 2012
0
0
By reprogramming a 7-year-old girl's own immune cells to attack an aggressive form of childhood leukemia, a pediatric oncologist has achieved a complete response in his patient, who faced grim prospects when she relapsed ...
Dec 9, 2012
0
1
(HealthDay)—In survivors of childhood hematologic malignancies who have received allogeneic hematopoietic stem cell transplantation (alloHSCT), body mass index (BMI) decreases significantly, mainly due to a reduction in ...
Oct 4, 2012
0
0
The answer to a 20-year-old physiology question may offer clues for the treatment and prevention of thrombosis and its related conditions, as well as heart attacks.
Sep 28, 2016
0
0
Individuals who are immunocompromised are at risk of worse COVID-19 outcomes and may have a less robust response to vaccination compared to non-immunocompromised individuals. But the term "immunocompromised" refers to a wide ...
Jan 24, 2024
0
9
